Disease Info Card

Anal Intraepithelial Neoplasia

Information about Anal Intraepithelial Neoplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Anal Intraepithelial Neoplasia

Most recent studies have shown that Anal Intraepithelial Neoplasia shares some biological mechanisms with acute-interstitial-nephritis, anal-carcinoma, anus-neoplasms, carcinoma, carcinoma-in-situ, condylomata-acuminata, dysplasia, hiv-infections, immunologic-deficiency-syndromes, infective-disorder, intraepithelial-neoplasia, kidney-failure, kidney-failure-acute, malignant-neoplasms, malignant-squamous-cell-neoplasm, neoplasms, nephritis, nephritis-interstitial, papillomavirus-infections, precancerous-conditions.

Among the many pathways, these few ones have gauged particular interests from scientists studying Anal Intraepithelial Neoplasia, and have been seen in publications frequently: Aging, Cell Cycle, Cell Proliferation, Coagulation, Dna Methylation, Epithelial Cell Proliferation, Excretion, Glomerular Filtration, Hypersensitivity, Immune Response, Inflammatory Response, Innervation, Localization, Pathogenesis, Phagocytosis, Quorum Sensing, Reflex, Regeneration, Secretion, Transport

Quite a number of genes have been found to play important roles in Anal Intraepithelial Neoplasia, such as ALB, ASAP1, ASAP2, CAT, CD4, CDKN2A, CRP, CSF3, IL6, MRPS30, PAPOLA, PDAP1, PDXP, PTGS2, REG3A, SERPINB3, TNF, TUSC2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.